Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ‐ prevalence, clinical impact, economic implications and management strategies

Documenti analoghi

• Meta‐Analysis: Global Prevalence and Mortality of Cirrhosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease
  di: Soroor Owrangi, et al.
  Pubblicazione: (2024)
• Editorial: Paradox of liver fat content in the spectrum of non‐alcoholic fatty liver disease
  di: Sung Won Chung, et al.
  Pubblicazione: (2024)
• Letter: Enhancing patient support through social work—Addressing economic challenges and medication non‐adherence in liver disease management
  di: Min Wu, et al.
  Pubblicazione: (2024)
• UK guideline on the transition and management of childhood liver diseases in adulthood
  di: Deepak Joshi, et al.
  Pubblicazione: (2024)
• Meta‐analysis: Efficacy and safety of fibroblast growth factor 21 analogues for the treatment of non‐alcoholic steatohepatitis and non‐alcoholic steatohepatitis‐related fibrosis
  di: Rutao Lin, et al.
  Pubblicazione: (2024)